1

Pik3CA Mutant Clear Cell Ovarian, Endometrial, Colorectal Cancers

SER-ISD1-001 - A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Adult Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss

Locations

• University of Alabama, Birmingham AL

• Hoag, Newport Beach CA

• Pacific Cancer Specialists, Anaheim CA 

• WCRN-COGI, Fresno CA

• Valkyrie Clinical Trials, Los Angeles CA

• University of Chicago, Chicago IL 

• Mayo Clinic, Rochester MN

• East Carolina University, Greenville NC

• Memorial Sloan Kettering, New York NY

• University of Pennsylvania, Philadelphia PA

• Avera, Sioux Falls SD

• Baptist Hospitals of Southeast Texas, Beaumont TX

• University of Texas Southwestern, Dallas TX 

• Medical College of Wisconsin, Milwaukee WI

Find out if you are eligible

​

Learn more at clinicaltrials.gov

2

Pancreatic Cancer

NEAAR-001: Medical Food for the Dietary Management of Metastatic Pancreatic Cancer

Locations

• University of Arizona Cancer Center, Tucson AZ

• Cedars Sinai, Los Angeles CA 

• Hoag, Newport Beach CA

• SCRI- Florida Cancer Specialists South, Fort Myers FL

• Louisiana State University, Shreveport LA 

• Atlantic Health, Morristown NJ

• SCRI-Tennessee Oncology Nashville, Nashville TN

• Medical College of Wisconsin, Milwaukee WI

• Baylor Scott and White, Temple TX 

• xCures Virtual site, USA

​

Find out if you are eligible

​

Learn more at clinicaltrials.gov

​

3

Colorectal Cancer
 

NEAAR-002: Medical Food for the Dietary Management of Metastatic Colorectal Cancer

Locations

• University of Arizona Cancer Center, Tucson AZ

• Cedars Sinai, Los Angeles CA 

• Pacific Cancer Specialists, Anaheim CA 

• Hoag, Newport Beach CA

• Memorial Sloan Kettering, New York NY

• University of Rochester Medical Center, Rochester NY

• Verdi Oncology, Nashville TN 

• University of Washington Fred Hutchinson, Seattle WA

​

​

Find out if you are eligible

​

Learn more at clinicaltrials.gov

​

​